Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations
Uloženo v:
| Název: | Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations |
|---|---|
| Autoři: | Dennis Lebeda, Adrian Fierenz, Lina Werfel, Rina Rosin-Arbesfeld, Julia Hofhuis, Sven Thoms |
| Přispěvatelé: | Lebeda, Dennis, Fierenz, Adrian, Werfel, Lina, Rosin-Arbesfeld, Rina, Hofhuis, Julia, Thoms, Sven |
| Zdroj: | J Mol Med (Berl) |
| Informace o vydavateli: | Springer Science and Business Media LLC, 2024. |
| Rok vydání: | 2024 |
| Témata: | 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, HEK293 Cells, Codon, Nonsense, Methyl-CpG-Binding Protein 2, Protein Biosynthesis, Rett Syndrome, Codon, Terminator, Humans, Original Article, RNA, Messenger, Methyl-CpG-Binding Protein 2/genetics [MeSH], Rare disease, Humans [MeSH], Aminoglycoside, RNA, Messenger/genetics [MeSH], Codon, Nonsense [MeSH], Protein Biosynthesis [MeSH], Translational readthrough, Rett Syndrome/metabolism [MeSH], Rett Syndrome/genetics [MeSH], Personalized medicine, Methyl-CpG-Binding Protein 2/metabolism [MeSH], HEK293 Cells [MeSH], Codon, Terminator [MeSH], Rett syndrome, RNA, Messenger/metabolism [MeSH] |
| Popis: | Abstract Rett syndrome (RTT) is a neurodevelopmental disorder resulting from genetic mutations in the methyl CpG binding protein 2 (MeCP2) gene. Specifically, around 35% of RTT patients harbor premature termination codons (PTCs) within the MeCP2 gene due to nonsense mutations. A promising therapeutic avenue for these individuals involves the use of aminoglycosides, which stimulate translational readthrough (TR) by causing stop codons to be interpreted as sense codons. However, the effectiveness of this treatment depends on several factors, including the type of stop codon and the surrounding nucleotides, collectively referred to as the stop codon context (SCC). Here, we develop a high-content reporter system to precisely measure TR efficiency at different SCCs, assess the recovery of the full-length MeCP2 protein, and evaluate its subcellular localization. We have conducted a comprehensive investigation into the intricate relationship between SCC characteristics and TR induction, examining a total of 14 pathogenic MeCP2 nonsense mutations with the aim to advance the prospects of personalized therapy for individuals with RTT. Our results demonstrate that TR induction can successfully restore full-length MeCP2 protein, albeit to varying degrees, contingent upon the SCC and the specific position of the PTC within the MeCP2 mRNA. TR induction can lead to the re-establishment of nuclear localization of MeCP2, indicating the potential restoration of protein functionality. In summary, our findings underscore the significance of SCC-specific approaches in the development of tailored therapies for RTT. By unraveling the relationship between SCC and TR therapy, we pave the way for personalized, individualized treatment strategies that hold promise for improving the lives of individuals affected by this debilitating neurodevelopmental disorder. Key messages The efficiency of readthrough induction at MeCP2 premature termination codons strongly depends on the stop codon context. The position of the premature termination codon on the transcript influences the readthrough inducibility. A new high-content dual reporter assay facilitates the measurement and prediction of readthrough efficiency of specific nucleotide stop contexts. Readthrough induction results in the recovery of full-length MeCP2 and its re-localization to the nucleus. MeCP2 requires only one of its annotated nuclear localization signals. |
| Druh dokumentu: | Article Other literature type |
| Jazyk: | English |
| ISSN: | 1432-1440 0946-2716 |
| DOI: | 10.1007/s00109-024-02436-6 |
| Přístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/38430393 https://pub.uni-bielefeld.de/record/2987678 https://doi.org/10.1007/s00109-024-02436-6 https://resolver.sub.uni-goettingen.de/purl?gro-2/142422 https://sfb1002.med.uni-goettingen.de/production/literature/publications/512 https://repository.publisso.de/resource/frl:6521575 |
| Rights: | CC BY "In Copyright" Rights Statement |
| Přístupové číslo: | edsair.doi.dedup.....ddab52863cdc5228e5669d82b5d647e8 |
| Databáze: | OpenAIRE |
| Abstrakt: | Abstract Rett syndrome (RTT) is a neurodevelopmental disorder resulting from genetic mutations in the methyl CpG binding protein 2 (MeCP2) gene. Specifically, around 35% of RTT patients harbor premature termination codons (PTCs) within the MeCP2 gene due to nonsense mutations. A promising therapeutic avenue for these individuals involves the use of aminoglycosides, which stimulate translational readthrough (TR) by causing stop codons to be interpreted as sense codons. However, the effectiveness of this treatment depends on several factors, including the type of stop codon and the surrounding nucleotides, collectively referred to as the stop codon context (SCC). Here, we develop a high-content reporter system to precisely measure TR efficiency at different SCCs, assess the recovery of the full-length MeCP2 protein, and evaluate its subcellular localization. We have conducted a comprehensive investigation into the intricate relationship between SCC characteristics and TR induction, examining a total of 14 pathogenic MeCP2 nonsense mutations with the aim to advance the prospects of personalized therapy for individuals with RTT. Our results demonstrate that TR induction can successfully restore full-length MeCP2 protein, albeit to varying degrees, contingent upon the SCC and the specific position of the PTC within the MeCP2 mRNA. TR induction can lead to the re-establishment of nuclear localization of MeCP2, indicating the potential restoration of protein functionality. In summary, our findings underscore the significance of SCC-specific approaches in the development of tailored therapies for RTT. By unraveling the relationship between SCC and TR therapy, we pave the way for personalized, individualized treatment strategies that hold promise for improving the lives of individuals affected by this debilitating neurodevelopmental disorder. Key messages The efficiency of readthrough induction at MeCP2 premature termination codons strongly depends on the stop codon context. The position of the premature termination codon on the transcript influences the readthrough inducibility. A new high-content dual reporter assay facilitates the measurement and prediction of readthrough efficiency of specific nucleotide stop contexts. Readthrough induction results in the recovery of full-length MeCP2 and its re-localization to the nucleus. MeCP2 requires only one of its annotated nuclear localization signals. |
|---|---|
| ISSN: | 14321440 09462716 |
| DOI: | 10.1007/s00109-024-02436-6 |
Full Text Finder
Nájsť tento článok vo Web of Science